TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

Top Trader Explains Why Stocks Had Worst Day of 2017
Play
MARKETS

Dow Lower as Wall Street Preps for an Eventful Week

Top Trader Explains Why Stocks Had Worst Day of 2017
MARKETS

Dow Lower as Wall Street Preps for an Eventful Week

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
INVESTING

Merck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 Billion

Biogen Wins a Battle, Not the War Against Alzheimer's
INVESTING

ArQule Jumps on Positive Phase 1 Blood Cancer Trial Results

Today's Pre-Market Mover With Heavy Volume: Physicians Realty (DOC)
MARKETS

Insider Trading Alert - SUMR, CVO And ARQL Traded By Insiders

Trade-Ideas: MetLife (MET) Is Today's Post-Market Leader Stock
MARKETS

Insider Trading Alert - ARQL, MTSC And PFNX Traded By Insiders

New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Insider Trading Alert - SAVE, ARQL And THST Traded By Insiders

New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Insider Trading Alert - ORM, OLBK And ARQL Traded By Insiders

Perilous Reversal Watch: Golar LNG (GLNG)
MARKETS

Insider Trading Alert - TIPT, RDNT And ARQL Traded By Insiders

3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Insider Trading Alert - ITG, CDXS And ARQL Traded By Insiders

4 Under-$10 Biotech Stocks in Breakout Territory
INVESTING

4 Biotech Stocks Under $10 to Watch for Breakout Trades

5 Stocks Under $10 Set to Soar
INVESTING

5 Stocks Under $10 Set to Soar

5 Bargain Bin Stocks to Buy in March
INVESTING

3 Stocks Under $10 Making Big Moves

Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies
STOCKS

10 ASCO '13 Abstracts You Can Read Right Now

4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

5 Under-$10 Stocks Setting Up to Trade Higher

5 Stocks Insiders Love Right Now
INVESTING

5 Stocks Poised for Breakouts

Investing Ahead of Earnings: Lennar, Nike and Tiffany
MARKETS

Dow Closes Lower; Nasdaq, S&P 500 Edge Up

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Arqule Shutters Lung Cancer Study Early Due to Futility

Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Arqule Shares Slide on Lung Cancer Drug Safety Concern

ASCO 2012 Live Blog -- Saturday
INVESTING

ASCO 2012 Live Blog -- Saturday

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

22 Biopharma Stocks With Breakout Potential in 2012

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update)

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

ASCO '12 Abstract Dump: Cancer Stocks in Focus

5 Stocks Insiders Love Right Now
INVESTING

3 Stocks Under $10 Moving Higher

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

7 Cancer Drug Stocks to Know Right Now